WAVE Clinical Platform
Excel Medical Electronics, LLC • Cardiovascular • 01/04/2018
Device Purpose
The WAVE Clinical Platform is a software solution designed to enhance clinical decision-making by aggregating, storing, and displaying comprehensive patient data from diverse hospital information systems and medical devices for remote access by healthcare professionals. Utilizing a client-server architecture on existing hospital networks, it provides near real-time and retrospective views of physiological data, waveforms, and alarms, intended to supplement primary monitoring systems.
Summary
The WAVE Clinical Platform, developed by Excel Medical Electronics, LLC, is a software system designed for healthcare professionals in hospital environments. Its core function is to route, store, and display a comprehensive range of patient information, including physiologic data, waveforms, alarms, diagnostic results, and data from Electronic Medical Records (EMR) and Clinical Information Systems (CIS). This capability supports remote consultation on patient status and enables clinicians to review critical near real-time and historical patient data, thereby aiding in informed clinical decision-making and facilitating timely patient care. The platform aims to integrate data from various supported devices and systems, making it accessible for review. Operating on a client-server architecture, the WAVE Clinical Platform utilizes existing hospital network infrastructure (both wired and wireless) and standard hardware for installation and data display on any web-enabled device. It gathers data from patient monitoring equipment, hospital information systems, and clinical analytics sources, offering both immediate and retrospective remote viewing, and can also forward these data to third-party systems. Notably, the platform does not control any connected medical devices. Data is archived and stored indefinitely on disk drives until deletion. It's crucial to understand that the WAVE Clinical Platform is intended to supplement, not replace, existing hospital monitoring or data management systems, and should not be the sole source for alarm notifications. Non-clinical performance evaluations, including system-level and user interface tests, have confirmed its safety, features, and operational performance.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What specific types of medical devices and physiological sensors has the WAVE Clinical Platform been validated to integrate with, and what is the process for adding new device compatibilities?; How does the platform ensure data integrity and security, especially when routing sensitive patient information across hospital networks and to third-party systems?; What are the typical latency times for displaying 'near real-time' data and alarms, and how might network variability within a hospital environment impact this performance?; Can the platform's data display be customized by different types of healthcare professionals (e.g., nurses, specialists, intensivists) to prioritize information relevant to their specific roles or workflows?; What mechanisms are in place for audit trails of data access and system interactions, particularly concerning remote consultations and clinical decisions made based on the platform's displayed information?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SaaSBOM, HBOM, OBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Not detected in AI-generated device summary: SBOM, ML-BOM, CBOM, VDR/VEX. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly